| A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis G Giovannoni, G Comi, S Cook, K Rammohan, P Rieckmann, ... New England Journal of Medicine 362 (5), 416-426, 2010 | 1182 | 2010 |
| Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind … G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ... The Lancet 374 (9700), 1503-1511, 2009 | 792 | 2009 |
| Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters P Flachenecker, T Kümpfel, B Kallmann, M Gottschalk, O Grauer, ... Multiple Sclerosis Journal 8 (6), 523-526, 2002 | 786 | 2002 |
| Monocyte/macrophage differentiation in early multiple sclerosis lesions W Brück, P Porada, S Poser, P Rieckmann, F Hanefeld, ... Annals of Neurology: Official Journal of the American Neurological …, 1995 | 614 | 1995 |
| Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. H Ehrenreich, RW Anderson, CH Fox, P Rieckmann, GS Hoffman, ... The Journal of experimental medicine 172 (6), 1741-1748, 1990 | 595 | 1990 |
| CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation RA Linker, M Mäurer, S Gaupp, R Martini, B Holtmann, R Giess, ... Nature medicine 8 (6), 620-624, 2002 | 476 | 2002 |
| Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity P Rieckmann, M Albrecht, B Kitze, T Weber, H Tumani, A Broocks, W Lüer, ... Annals of Neurology: Official Journal of the American Neurological …, 1995 | 438 | 1995 |
| New perspectives in the natural history of multiple sclerosis H Tremlett, Y Zhao, P Rieckmann, M Hutchinson Neurology 74 (24), 2004-2015, 2010 | 382 | 2010 |
| A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation M Mäurer, S Loserth, A Kolb-Mäurer, A Ponath, S Wiese, N Kruse, ... Immunogenetics 54, 1-8, 2002 | 361 | 2002 |
| Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study G Giovannoni, P Soelberg Sorensen, S Cook, K Rammohan, ... Multiple Sclerosis Journal 24 (12), 1594-1604, 2018 | 327 | 2018 |
| Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations Multiple Sclerosis Therapy Consensus Group (MSTCG), H Wiendl, ... Journal of neurology 255, 1449-1463, 2008 | 309 | 2008 |
| Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis P Rieckmann, M Albrecht, B Kitze, T Weber, H Tumani, A Broocks, W Luer, ... Neurology 44 (8), 1523-1523, 1994 | 309 | 1994 |
| Three times weekly glatiramer acetate in relapsing–remitting multiple sclerosis O Khan, P Rieckmann, A Boyko, K Selmaj, R Zivadinov, ... Annals of neurology 73 (6), 705-713, 2013 | 304 | 2013 |
| A PD‐1 polymorphism is associated with disease progression in multiple sclerosis A Kroner, M Mehling, B Hemmer, P Rieckmann, KV Toyka, M Mäurer, ... Annals of neurology 58 (1), 50-57, 2005 | 300 | 2005 |
| Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study K Selmaj, DKB Li, HP Hartung, B Hemmer, L Kappos, MS Freedman, ... The Lancet Neurology 12 (8), 756-767, 2013 | 286 | 2013 |
| Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup … G Giovannoni, S Cook, K Rammohan, P Rieckmann, PS Sørensen, ... The Lancet Neurology 10 (4), 329-337, 2011 | 281 | 2011 |
| Impact of multiple sclerosis relapses on progression diminishes with time H Tremlett, M Yousefi, V Devonshire, P Rieckmann, Y Zhao Neurology 73 (20), 1616-1623, 2009 | 271 | 2009 |
| The natural history of secondary progressive multiple sclerosis M Koch, E Kingwell, P Rieckmann, H Tremlett Journal of Neurology, Neurosurgery & Psychiatry 81 (9), 1039-1043, 2010 | 251 | 2010 |
| Plasma exchange for severe optic neuritis: treatment of 10 patients K Ruprecht, E Klinker, T Dintelmann, P Rieckmann, R Gold Neurology 63 (6), 1081-1083, 2004 | 239 | 2004 |
| The natural history of primary progressive multiple sclerosis M Koch, E Kingwell, P Rieckmann, H Tremlett Neurology 73 (23), 1996-2002, 2009 | 235 | 2009 |
